AR033681A1 - A COMPOUND DERIVED FROM 7-OXO-PYRIDOPIRIMIDINES, A PROCESS FOR OBTAINING IT, A COMPOSITION THAT CONTAINS IT AND A METHOD OF MANUFACTURE OF A MEDICINAL PRODUCT - Google Patents

A COMPOUND DERIVED FROM 7-OXO-PYRIDOPIRIMIDINES, A PROCESS FOR OBTAINING IT, A COMPOSITION THAT CONTAINS IT AND A METHOD OF MANUFACTURE OF A MEDICINAL PRODUCT

Info

Publication number
AR033681A1
AR033681A1 ARP010104132A ARP010104132A AR033681A1 AR 033681 A1 AR033681 A1 AR 033681A1 AR P010104132 A ARP010104132 A AR P010104132A AR P010104132 A ARP010104132 A AR P010104132A AR 033681 A1 AR033681 A1 AR 033681A1
Authority
AR
Argentina
Prior art keywords
alkyl
cycloalkyl
hydrogen
oxo
compound derived
Prior art date
Application number
ARP010104132A
Other languages
Spanish (es)
Inventor
Jian Jeffrey Chen
James Patrick Dunn
David Michael Goldstein
Julie Anne Lim
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR033681A1 publication Critical patent/AR033681A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Un compuesto derivado de 7-oxo-piridopirimidina de fórmula (1) en la cual R1 es hidrógeno o alquilo; R2 es cicloalquilo sustituido, cicloalquilo heterosustituido, cicloalquilo heteroalquilsustituido, cicloalquilalquilo, heterosustituido, heterociclilo, heterociclilo- espiro-cicloalquilo, aralcoxi, alcoxi, alquil-S(O)n-alquileno-(en el que n es el número 1 o 2) o -SO2-Ar2;; R3 es hidrogeno, amino, monoalquilamino, dialquilamino, acilamino, -NRa-C(=O)-Rb (en el que Ra es hidrógeno o alquilo y Rb es heterociclilo o heteroalquilo), alquilo, cicloalquilo, arilo, aralquilo, haloalquilo, heteroalquilo, cianoalquilo, -alquileno-C(O)-R (en el que R es hidrógeno, alquilo, hidroxi, alcoxi, amino, monoalquilamino o dialquilamino), acilo o ftalimidoalquilo; y Ar1 y Ar2 con independencia entre sí son en cada caso arilo; o sales farmacéuticamente aceptables o profármacos del mismo. Un proceso para su obtención, una composición que lo contiene y un método para la fabricación de un medicamento. El compuesto derivado de 7-oxo-piridopirimidina es útil para los trastornos causados por p38, en el que el trastorno causado por p38 se selecciona entre la artritis, la enfermedad de Crohn, la enfermedad de Alzheimer, el síndrome de intestino irritable, el síndrome de la deficiencia respiratoria adulta y la enfermedad pulmonar obstructiva crónica.A compound derived from 7-oxo-pyridopyrimidine of formula (1) in which R1 is hydrogen or alkyl; R2 is substituted cycloalkyl, heterosubstituted cycloalkyl, substituted heteroalkyl cycloalkyl, cycloalkylalkyl, hetero substituted, heterocyclyl, heterocyclyl-spiro-cycloalkyl, aralkoxy, alkoxy, alkyl-S (O) n-alkylene- (in which n is number 1 or 2) -SO2-Ar2 ;; R3 is hydrogen, amino, monoalkylamino, dialkylamino, acylamino, -NRa-C (= O) -Rb (where Ra is hydrogen or alkyl and Rb is heterocyclyl or heteroalkyl), alkyl, cycloalkyl, aryl, aralkyl, haloalkyl, heteroalkyl , cyanoalkyl, -alkylene-C (O) -R (where R is hydrogen, alkyl, hydroxy, alkoxy, amino, monoalkylamino or dialkylamino), acyl or phthalimidoalkyl; and Ar1 and Ar2 independently of each other are in each case aryl; or pharmaceutically acceptable salts or prodrugs thereof. A process for obtaining it, a composition that contains it and a method for the manufacture of a medicine. The compound derived from 7-oxo-pyridopyrimidine is useful for disorders caused by p38, in which the disorder caused by p38 is selected from arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, syndrome of adult respiratory deficiency and chronic obstructive pulmonary disease.

ARP010104132A 2000-08-31 2001-08-30 A COMPOUND DERIVED FROM 7-OXO-PYRIDOPIRIMIDINES, A PROCESS FOR OBTAINING IT, A COMPOSITION THAT CONTAINS IT AND A METHOD OF MANUFACTURE OF A MEDICINAL PRODUCT AR033681A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22958400P 2000-08-31 2000-08-31

Publications (1)

Publication Number Publication Date
AR033681A1 true AR033681A1 (en) 2004-01-07

Family

ID=22861859

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010104132A AR033681A1 (en) 2000-08-31 2001-08-30 A COMPOUND DERIVED FROM 7-OXO-PYRIDOPIRIMIDINES, A PROCESS FOR OBTAINING IT, A COMPOSITION THAT CONTAINS IT AND A METHOD OF MANUFACTURE OF A MEDICINAL PRODUCT

Country Status (15)

Country Link
EP (1) EP1315726A1 (en)
JP (1) JP4141830B2 (en)
KR (1) KR100571339B1 (en)
CN (1) CN1275964C (en)
AR (1) AR033681A1 (en)
AU (2) AU9378401A (en)
BR (1) BR0113628A (en)
CA (1) CA2420286A1 (en)
GT (1) GT200100191A (en)
MX (1) MXPA03001821A (en)
PA (1) PA8527301A1 (en)
PE (1) PE20020406A1 (en)
UY (1) UY26918A1 (en)
WO (1) WO2002018380A1 (en)
ZA (1) ZA200301079B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03001733A (en) * 2000-08-31 2003-05-27 Hoffmann La Roche 7-oxo pyridopyrimidines.
US6518276B2 (en) 2000-08-31 2003-02-11 Syntex (U.S.A.) Llc 7-oxo-pyridopyrimidines (II)
EP1492790A1 (en) * 2002-04-03 2005-01-05 F. Hoffmann-La Roche Ag Imidazo fused compounds
PL373339A1 (en) * 2002-04-19 2005-08-22 Smithkline Beecham Corporation Novel compounds
US7084270B2 (en) 2002-08-14 2006-08-01 Hoffman-La Roche Inc. Pyrimido compounds having antiproliferative activity
UY27939A1 (en) 2002-08-21 2004-03-31 Glaxo Group Ltd COMPOUNDS
US7112676B2 (en) 2002-11-04 2006-09-26 Hoffmann-La Roche Inc. Pyrimido compounds having antiproliferative activity
JP2006514624A (en) * 2002-11-18 2006-05-11 エフ．ホフマン−ラ　ロシュ　アーゲー Diazinopyrimidines
US7098332B2 (en) 2002-12-20 2006-08-29 Hoffmann-La Roche Inc. 5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
EP1615928A1 (en) 2003-04-10 2006-01-18 F.Hoffmann-La Roche Ag Pyrimido compounds
ATE451115T1 (en) * 2003-07-07 2009-12-15 Van Andel Res Inst INHIBITION OF TUMOR ANGIOGENESIS BY A COMBINATION OF THROMBOSPONDIN-1 AND VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS
DK1685131T3 (en) * 2003-11-13 2007-07-09 Hoffmann La Roche Hydroxyalkyl-substituted pyrido-7-pyrimidin-7-ones
WO2005105097A2 (en) * 2004-04-28 2005-11-10 Gpc Biotech Ag Pyridopyrimidines for treating inflammatory and other diseases
US20070054916A1 (en) * 2004-10-01 2007-03-08 Amgen Inc. Aryl nitrogen-containing bicyclic compounds and methods of use
WO2006056863A1 (en) * 2004-11-23 2006-06-01 Ranbaxy Laboratories Limited Pyrido’2, 3-d!pyrimidines as anti-inflammatory agents
WO2006082492A1 (en) * 2005-02-02 2006-08-10 Ranbaxy Laboratories Limited Azabicyclo derivatives as anti-inflammatory agents
EP1931667A1 (en) * 2005-09-28 2008-06-18 Ranbaxy Laboratories Limited Pyrido-pyridimidine derivatives useful as antiinflammatory agents
CN101374840B (en) 2006-01-31 2011-09-28 霍夫曼-拉罗奇有限公司 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
KR100661523B1 (en) * 2006-06-09 2006-12-26 주식회사 청용산기 Box correcting device of stitching progress for carton box erecting
EP1914234A1 (en) 2006-10-16 2008-04-23 GPC Biotech Inc. Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors
EP2094698A1 (en) 2006-11-09 2009-09-02 F. Hoffmann-Roche AG Substituted 6-phenyl-pyrido [2,3-d]pyrimidin-7-one derivatives as kinase inhibitors and methods for using the same
WO2008078249A1 (en) * 2006-12-21 2008-07-03 Ranbaxy Laboratories Limited Anti-inflammatory agents
EP2112150B1 (en) 2008-04-22 2013-10-16 Forma Therapeutics, Inc. Improved raf inhibitors
KR101106162B1 (en) * 2010-04-20 2012-01-20 주식회사 청용산기 Stitching device for packing box making apparatus
ES2694223T3 (en) * 2012-03-22 2018-12-19 Oscotec, Inc. Pyridopyrimidine compounds and their use as FLT3 inhibitors
CN111793068A (en) 2013-03-15 2020-10-20 西建卡尔有限责任公司 Heteroaryl compounds and uses thereof
US9321786B2 (en) 2013-03-15 2016-04-26 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
EP3943087A1 (en) 2013-03-15 2022-01-26 Celgene CAR LLC Heteroaryl compounds and uses thereof
CA2958331C (en) 2014-09-12 2019-12-17 Biolab Sanus Farmaceutica Ltda. New pyridopyrimidines derivatives compounds
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
CA3128468A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
TWI748317B (en) 2019-01-03 2021-12-01 美商建南德克公司 Pyrido-pyrimidinone and pteridinone compounds and methods of use
PE20220387A1 (en) * 2019-05-31 2022-03-18 Servier Lab HETEROBICYCLIC MAT2A INHIBITORS AND METHODS OF USE FOR THE TREATMENT OF CANCER
WO2022052924A1 (en) * 2020-09-11 2022-03-17 上海凌达生物医药有限公司 Preparation method for class of nitrogen-containing fused ring compounds and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0790997B1 (en) * 1994-11-14 2000-03-22 Warner-Lambert Company 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
IL117923A (en) * 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
ID27589A (en) * 1998-05-26 2001-04-12 Warner Lambert Comapny BICYCLIC PYYRIMINE AND DIHYDROPIRYMIDINE BICYCLIC 3,4 AS A RESULTS OF MOBILE PROLIFERATION

Also Published As

Publication number Publication date
MXPA03001821A (en) 2003-06-04
AU2001293784B2 (en) 2007-08-30
BR0113628A (en) 2003-07-01
UY26918A1 (en) 2002-02-28
CN1451005A (en) 2003-10-22
ZA200301079B (en) 2004-05-07
JP4141830B2 (en) 2008-08-27
CN1275964C (en) 2006-09-20
KR100571339B1 (en) 2006-04-17
AU9378401A (en) 2002-03-13
CA2420286A1 (en) 2002-03-07
JP2004507541A (en) 2004-03-11
PE20020406A1 (en) 2002-05-17
WO2002018380A1 (en) 2002-03-07
GT200100191A (en) 2002-05-16
PA8527301A1 (en) 2002-07-30
EP1315726A1 (en) 2003-06-04
KR20030022422A (en) 2003-03-15

Similar Documents

Publication Publication Date Title
AR033681A1 (en) A COMPOUND DERIVED FROM 7-OXO-PYRIDOPIRIMIDINES, A PROCESS FOR OBTAINING IT, A COMPOSITION THAT CONTAINS IT AND A METHOD OF MANUFACTURE OF A MEDICINAL PRODUCT
CY1111071T1 (en) PHARMACEUTICAL COMPOUNDS CONTAINING THE AZETIDIN PRODUCERS, THE NEW AZETIDIN PRODUCERS AND THEIR PREPARATION
ES2083359T3 (en) PIPERIDINES 1,4-SUBSTITUTED AS ACHETYLCHOLINESTERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF ALZHEIMER DISEASE.
PT89623B (en) PROCESS FOR THE PREPARATION OF INDOLCARBAZOLE AND PHARMACEUTICAL COMPOSITIONS DERIVATIVES CONTAINING THESE COMPOUNDS
IS2293B (en) Aryl fused azapolycyclic compounds
ATE260263T1 (en) HETEROAROMATIC BIZYCLIC COMPOUNDS HAVING ANTI-CANCER EFFECT
MXPA05006420A (en) Pyrimidine derivates for the treatment of abnormal cell growth.
ES2187644T3 (en) DERIVATIVES OF ACETAMIDE, MANUFACTURING PROCEDURE AND DRUG COMPOSITION BASED ON THESE DERIVATIVES.
AR015312A1 (en) UNION PEPTIDILIC INHIBITING COMPOUNDS TO VLA-4 DEPENDENT CELLS USEFUL IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND RESPIRATORY DISEASES, PHARMACEUTICAL COMPOSITION AND USE OF COMPOUNDS IN THE PREPARATION OF MEDICINES
SE0202241D0 (en) Novel Compounds
DE60229530D1 (en) SUBSTITUTED PIPERAZINE AS MODULATORS OF MELANOCORTINRECEPTOR
ATE239012T1 (en) TRIAZINE ANGIOGENESIS INHIBITORS
MY139357A (en) Novel benzoimidazole derivatives useful as antiproliferative agents
AR053149A1 (en) USE OF DIOSMETINE COMPOUNDS FOR OBTAINING PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE PREVENTION AND / OR TREATMENT OF THROMBOTIC PATHOLOGIES AND PATHOLOGIES THAT CONCLUDE THE RISK OF PRODUCING THROMBOSIS
DK1200426T3 (en) Substituted thien-3-yl-sulfonylamino (thio) carbonyl-thiazoline (thi) ones
PE20040778A1 (en) SELECTIVELY ACTIVE PIPERAZINE DERIVATIVES ON MC-3 AND MC-4 MELANCORTINE RECEPTORS
AR012489A1 (en) CORTICOTROPIN RELEASE FACTOR THIOPHENOPYRIDINE ANTAGONISTS. PROCEDURE FOR ITS PREPARATION, THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM, PROCEDURE FOR THE PREPARATION OF SUCH COMPOSITION, AN INTERMEDIATE COMPOUND AND
JP2004507540A5 (en)
BR0215017A (en) Lactams as Tachykinin Antagonists
AR033996A1 (en) A 7-OXO-PYRIDOPIRIMIDINE, ITS USE, A PROCESS TO PREPARE IT, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PROCESS TO PRODUCE A PYRIMIDINE, A PROCESS TO PRODUCE A PYRIDOPIRIMIDINE, AND PREPARED COMPOUNDS THROUGH
BR0315839A (en) Proline derivatives having affinity for the alpha-2-delta calcium channel subunit
NO975028D0 (en) Piperazine derivatives as neurokinin antagonists
AR015233A1 (en) SULFONAMIDS, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THE USE OF THE SAME FOR THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF THROMBOEMBOLIC DISORDERS.
DE602005026557D1 (en) 1-Ä (6-SUBSTITUTED ALKOXYCHINOXALINYL) AMINOCARBONYLÜ-4- (HETERO) ARYLPIPERAZINE DERIVATIVES
AR054414A1 (en) ESPIRO-HYDANTOINE COMPOUNDS REPLACED WITH PIRIDILE. PHARMACEUTICAL COMPOSITIONS.

Legal Events

Date Code Title Description
FB Suspension of granting procedure